EHV with inactivated UL18 and/or UL8
US11384365B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Inventors
Key dates
| Filing date | Mar 19, 2019 |
| Grant date | Jul 12, 2022 |
| Priority date | — |
| Expiry date | Mar 19, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16071
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of (vector) vaccines, and especially to novel EHV's having an inactivation of UL18 and/or UL8. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.